News & Updates
Filter by Specialty:
GLP-1RAs reduce weight in overweight/obese individuals without diabetes
30 Sep 2023
byStephen Padilla
Treatment with glucagon-like peptide-1 receptor agonists (GLP-1RAs) results in significant weight loss in patients with obesity or overweight without diabetes, a study has shown. In addition, the best GLP-1RA agent appears to be semaglutide, showing superior efficacy and low-to-moderate risk of side effects.
GLP-1RAs reduce weight in overweight/obese individuals without diabetes
30 Sep 2023Use of 5αRI does not increase cardiovascular risk in men with BPH
30 Sep 2023
Treatment with five-alpha reductase inhibitors (5αRIs) does not appear to elevate the risk of hospitalization for heart failure (HF), myocardial infarction (MI), stroke, or cardiovascular death among men with benign prostatic hyperplasia (BPH), a study has shown.